Stock Alert: Apyx Stock Up 43% In Pre-Market On Approval To Sell Helium Products In New Countries

(RTTNews) - Shares of Apyx Medical Corp. (APYX) are rallying over 43% in pre-market today, after the company announced that it has obtained regulatory approval to market and sell its Helium Plasma Technology products in five new countries: Australia, Brazil, Israel, Taiwan and Thailand. The company has contracted with distributors to market and sell its products in each country.

"We are very pleased to obtain regulatory approvals to market and sell our Helium Plasma Technology products in these five new countries," said Charlie Goodwin, President and Chief Executive Officer. "We have been focused on pursuing regulatory clearances in international markets as one of our key strategic priorities to enhance Apyx Medical's long-term growth profile..."

The stock has been trading in the range of $2.80 - $8.59 for the past one year, and closed Monday's trade at $4.78, up 10 cents or 2.14%. APYX is currently trading at $6.88, up $2.10 or 43.93% in the pre-market session.